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Introduction
Clawed toes, defined as extension of the metatarsophalan-
geal joint (MTPJ) and flexion of the proximal and distal
interphalangeal joints (IPJ), have been associated with the
diabetic foot. One theory states that this deformity is
caused by an imbalance between the extrinsic and intrin-
sic foot muscles [1,2]. However, Bus et al. found a 73%
decrease in intrinsic muscle cross sectional area between
diabetic neuropathic patients and controls, but only 2 of
8 neuropathic patients had toe deformities [3]. Anderson
et al. found that diabetic neuropathic patients had a little
more than 50% of the intrinsic muscle volume of either
controls or non-neuropathic diabetic patients, but none
of the diabetic neuropathic patients had toe deformities
[4]. Others have found a link between plantar apo-neuro-
sis (PA) dysfunction and clawed toes [5,6] and between
diabetes and a thicker PA [7-9]. The purpose of this study
was to explore the relationship between claw toes, neu-
ropathy, intrinsic muscle volume and PA thickness.
Methods
We enrolled 40 diabetic subjects in 4 groups: G1) neuro-
pathic, claw toes, G2) neuropathic, no claw toes, G3) non-
neuropathic, claw toes, and G4) non-neuropathic, no
claw toes. We have analyzed a subset for this abstract (G1:
n = 6, G2: n = 4, G3: n = 6, G4: n = 4). The presence of claw
toes was determined via clinical exam and neuropathy
was defined as insensitivity to a 10 g monofilament. Par-
tial weight-bearing CT scans were taken for each foot.
Intrinsic muscle volume was determined by segmenting
each foot using MultiRigid; data were normalized to total
foot volume. PA thickness was measured at 1/5 the dis-
tance from the heel to the base of the first metatarsal using
ImageJ. A two-way analysis of variance was used to test for
interaction and significance (p < 0.05).
Results
There was significant interaction between foot deformity
and neuropathy (p = 0.02). Feet with both neuropathy
and foot deformity had lower mean volume than all the
other groups, i.e., volume was reduced only when feet
were both neuropathic and had deformity (Table 1).
Mean PA thickness was significantly higher for feet with
foot deformities than those without (p = 0.019) (Table 2).
Thickness was also higher in neuropathic feet than in non-
neuropathic feet, but this difference was not significant (p
= 0.14). While the data suggests that thickness was highest
in feet that had both neuropathy and deformity beyond
the additive effects of each factor separately, the interac-
tion between deformity and neuropathy was not signifi-
cant (p = 0.2).
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Table 1: Intrinsic muscle volume (mean ± SD)
claw toes yes claw toes no
neuropathy yes 0.130 ± 0.037 0.191 ± 0.008
neuropathy no 0.198 ± 0.018 0.192 ± 0.034Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Foot and Ankle Research 2008, 1(Suppl 1):O2 http://www.jfootankleres.com/content/1/S1/O2
Page 2 of 2
(page number not for citation purposes)
Conclusion
Our pilot study demonstrates that neuropathic feet with
claw toes have less intrinsic muscle volume than the other
groups. The same feet also had thicker PA, suggesting that
both intrinsic muscle atrophy and PA dysfunction are
required for the development of claw toes. The specific
mechanism of clawing with a thicker PA (as opposed to a
ruptured PA, as seen previously [5,6]) is not yet under-
stood.
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Table 2: PA thickness (mean ± SD)
claw toes yes claw toes no
neuropathy yes 4.57 ± 1.19 2.96 ± 0.22
neuropathy no 3.51 ± 0.99 3.00 ± 0.20